Cytogenetics of multiple myeloma

Area of Science:

• Hematology
• Cytogenetics
• Cancer Biology

Background:

• Multiple myeloma (MM) is a hematologic malignancy characterized by genetic instability.
• Specific chromosomal aberrations in MM have been linked to patient prognosis and disease progression.
• Understanding these genetic alterations is crucial for developing targeted therapies and improving patient outcomes.

Purpose of the Study:

• To investigate the frequency and types of chromosomal abnormalities in a cohort of multiple myeloma patients.
• To assess the prognostic significance of identified cytogenetic changes in MM.

Main Methods:

• Cytogenetic analysis and fluorescent in situ hybridization (FISH) were performed on 43 MM patient samples.
• Karyotyping was used to identify numerical and structural chromosomal abnormalities.
• Specific chromosomal regions and translocations, including del(13q) and t(11;14), were analyzed.

Main Results:

• Clonal chromosomal changes were detected in 56% of the analyzed MM cases.
• Hyperdiploid karyotype was the most common (50%), followed by hypodiploid (33%) and pseudodiploid (17%).
• Frequent numerical abnormalities included gains of chromosomes 15, 11, 3, 6 and losses of X, 13, 14, 8. Structural rearrangements, such as del(1p), dup(1q), del(5q), del(13q), del(17p), and t(11;14), were observed in 71% of cases. Deletions of chromosome 13 (chromosome -13/13q deletion) were found in 42% of cases, with complete loss in 67% of those.
• A mixture of abnormal and normal metaphases was observed in most cases.

Conclusions:

• Cytogenetic and FISH analyses are essential for characterizing chromosomal abnormalities in multiple myeloma.
• The identified chromosomal changes, particularly chromosome 13 abnormalities and t(11;14), are prevalent and likely hold prognostic value in MM.
• Further research correlating these findings with clinical outcomes is warranted to refine prognostic models and guide treatment strategies.